Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 21, 2021 | IPO | $200M | — | — | — | Detail |
Mar 23, 2021 | Series Unknown | $125M | 9 | Casdin Capital , Redmile Group | — | Detail |
Feb 22, 2021 | Corporate Round | — | 1 | Merck Global Health Innovation Fund | — | Detail |
Oct 20, 2020 | Series E | $69.99M | 4 | Casdin Capital | — | Detail |
Jan 14, 2020 | Series D | $10.40M | 6 | JSR Life Sciences , KBI Biopharma | — | Detail |
Dec 7, 2019 | Debt Financing | $5M | — | — | — | Detail |
Jan 7, 2019 | Series D | $10.36M | 2 | JSR Corp , KBI Biopharma | — | Detail |
May 30, 2018 | Series C | $12M | 7 | AGC | — | Detail |
Aug 14, 2017 | Series B | — | 1 | Phoenix Venture Partners | — | Detail |
Feb 2, 2016 | Series A | $5.10M | 3 | Phoenix Venture Partners | — | Detail |
Jan 1, 2013 | Seed | — | — | — | — | Detail |